IntegriChain Insights

In episode two of IntegriChain's 340B Series podcast, we're joined by Clay Willis, Partner of Advisory Services at IntegriChain. With years of hands-on experience guiding biopharma manufacturers and life sciences organizations through the 340B landscape, Clay unpacks key trends like duplicate discounts and the program's ongoing growth, along with practical strategies for managing an...

In the debut episode of IntegriChain's new 340B Series podcast, we sit down with Clay Willis, Partner of Advisory Services at IntegriChain. Clay brings years of hands-on experience helping biopharma manufacturers and life sciences organizations navigate the 340B landscape, including duplicate discount trends and the channel's continued growth, along with the strategies companies can use...

In this inaugural episode of IntegriChain’s Gross-to-Net Podcast , Jen Sharpe and Brittany Honeycutt share their personal journeys into revenue accounting and consulting, offering insights into how they built their careers in the life sciences industry. They reflect on the experiences that shaped their passion for gross-to-net and government pricing, from early roles in auditing and pharma finance...

Join VP of Industry Solutions at IntegriChain, Dave Weiss, Senior VP of Data Solutions at IntegriChain, Jeff Uccello, and Partner at Blue Fin Group, Reena Patel, for a deep dive into Asembia 2024. They'll discuss the key takeaways, with a focus on how the life science industry is navigating economic pressures and embracing technology and AI for success. Registration is open for the Access Ins...

Disclaimer: IntegriChain is providing this podcast as a customer service, but it is neither a legal interpretation nor a statement of IntegriChain's views or policy. Reference to any specific product or entity does not constitute an endorsement or recommendation by IntegriChain. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of th...